Connect endotyping with host-directed therapies |
Use clinical and biological data to establish and better delineate endotypes of pneumonia |
Develop metrics for assigning endotypes to individual patients |
Test abilities of already available host-directed therapies to improve pneumonia treatment, guided by endotype |
Develop and test novel endotype-directed therapies for pneumonia, based on advances in mechanistic understanding |
|
|
Generate predictive tools for pneumonia |
For those with risk factors, develop measurements that discriminate who will most likely get pneumonia |
For those with pneumonia, develop measurements that discriminate who will most likely experience clinical failure |
For those recovering, develop measurements that discriminate who will most likely have recurrence, cardiovascular events, pulmonary decrements, cognitive decline, or other sequelae |
|
|
Elucidate defense mechanisms in the protected lung |
Refine, improve, or develop alternatives for approaches to better studying the protected lung |
Determine how lung defense is affected by earlier life experiences, including antecedent respiratory infections |
Define defense roles of cells within the lung interstitium |